Filing Details

Accession Number:
0001144204-16-095611
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-21 18:03:20
Reporting Period:
2016-04-20
Filing Date:
2016-04-21
Accepted Time:
2016-04-21 18:03:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1279704 Cellectar Biosciences Inc. CLRB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1167426 John Neis C/O Cellectar Biosciences, Inc.
3301 Agriculture Drive
Madison WI 53716
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.00001 Per Share Acquisiton 2016-04-20 234,742 $2.12 297,984 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Warrants Acquisiton 2016-04-20 234,742 $0.01 234,742 $3.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
274,613 2016-04-20 2021-04-20 No 4 P Indirect
Footnotes
  1. These securities are held by Venture Investors Early Stage fund IV Limited Partnership and Advantage Capital Wisconsin Partners I, Limited Partnership. VIESF IV GP LLC is the general partner of Venture Investors Early Stage Fund IV Limited Partnership and Venture Investors LLC is the submanager and special limited partner of Advantage Capital Wisconsin Partners I, Limited Partnership. The investment decisions of VIESF IV GP LLC and Venture Investors LLC are made collectively by seven managers, including the reporting person. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest herein.